Randomized, Double-Blind, Multicenter, Placebo-Controlled Study To Evaluate Efficacy And Safety Of Pregabalin(CI-1008)In The Treatment Of Fibromyalgia
Randomized, Double-Blind, Multicenter, Placebo-Controlled Study To Evaluate Efficacy And Safety Of Pregabalin(CI-1008)In The Treatment Of Fibromyalgia
This study, will compare pregabalin with placebo for the duration of 15 weeks to evaluate the efficacy and safety of pregabalin in patients with fibromyalgia.
Inclusion Criteria:
Exclusion Criteria:
Ichihara-shi, Chiba, Japan
Yotukaidou, Chiba, Japan
Matuyama-si, Ehime, Japan
Iiduka, Fukuoka, Japan
Sagamihara-shi, Kanagawa, Japan
Koushi, Kumamoto, Japan
Hiki-gun, Saitama, Japan
Saitama-shi, Saitama, Japan
Aoi-ku, Shizuoka, Japan
Shimotsuga-gun, Tochigi, Japan
Bunkyo-ku, Tokyo, Japan
Chiyoda-ku, Tokyo, Japan
Chuou-Ku, Tokyo, Japan
Itabashi-Ku, Tokyo, Japan
Setagaya-ku, Tokyo, Japan
Shinagawa-Ku, Tokyo, Japan